These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 34838052

  • 1. Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7.
    Zuo R, Ye LF, Huang Y, Song ZQ, Wang L, Zhi H, Zhang MY, Li JY, Zhu L, Xiao WJ, Shang HC, Zhang Y, He RR, Chen Y.
    J Nanobiotechnology; 2021 Nov 27; 19(1):396. PubMed ID: 34838052
    [Abstract] [Full Text] [Related]

  • 2. Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux.
    Chen X, Chen S, Pang J, Huang R, You Y, Zhang H, Xiao J, Xue H, Ling W.
    J Hepatol; 2023 Dec 27; 79(6):1491-1501. PubMed ID: 37678722
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1.
    Jiang F, Chen Q, Wang W, Ling Y, Yan Y, Xia P.
    J Hepatol; 2020 Jan 27; 72(1):156-166. PubMed ID: 31568800
    [Abstract] [Full Text] [Related]

  • 4. Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.
    Chen Y, Wang L, Pitzer AL, Li X, Li PL, Zhang Y.
    J Mol Med (Berl); 2016 Dec 27; 94(12):1335-1347. PubMed ID: 27783111
    [Abstract] [Full Text] [Related]

  • 5. Contribution of cathepsin B-dependent Nlrp3 inflammasome activation to nicotine-induced endothelial barrier dysfunction.
    Zhang Y, Chen Y, Zhang Y, Li PL, Li X.
    Eur J Pharmacol; 2019 Dec 15; 865():172795. PubMed ID: 31733211
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K, Zhu X, Liu Y, Miao C, Wang T, Li P, Zhao L, Chen Y, Gong J, Cai C, Li J, Li S, Ruan XZ, Gong J.
    Oncotarget; 2017 Jun 06; 8(23):37657-37672. PubMed ID: 28499273
    [Abstract] [Full Text] [Related]

  • 7. Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1.
    Chen Y, Pitzer AL, Li X, Li PL, Wang L, Zhang Y.
    J Cell Mol Med; 2015 Dec 06; 19(12):2715-27. PubMed ID: 26293846
    [Abstract] [Full Text] [Related]

  • 8. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y, Cao G, Min X, Wang T, Sun S, Du X, Zhang W.
    J Physiol Biochem; 2018 Nov 06; 74(4):503-510. PubMed ID: 30019185
    [Abstract] [Full Text] [Related]

  • 9. Contribution of Hepatic Steatosis-Intensified Extracellular Vesicle Release to Aggravated Inflammatory Endothelial Injury in Liver-Specific Asah1 Gene Knockout Mice.
    Yuan X, Bhat OM, Zou Y, Zhang Y, Li PL.
    Am J Pathol; 2023 Apr 06; 193(4):493-508. PubMed ID: 36638912
    [Abstract] [Full Text] [Related]

  • 10. NLRP3 inflammasome activation is required for fibrosis development in NAFLD.
    Wree A, McGeough MD, Peña CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE.
    J Mol Med (Berl); 2014 Oct 06; 92(10):1069-82. PubMed ID: 24861026
    [Abstract] [Full Text] [Related]

  • 11. Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice.
    Zhang Y, Wen J, Liu D, Qiu Z, Zhu Q, Li R, Zhang Y.
    Life Sci; 2021 Sep 15; 281():119778. PubMed ID: 34192596
    [Abstract] [Full Text] [Related]

  • 12. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1.
    Xiang W, Yang Y, Weng L, Ye Z, Ding P, Li H, Sun J, Zeng C.
    Int Immunopharmacol; 2023 May 15; 118():110085. PubMed ID: 37018978
    [Abstract] [Full Text] [Related]

  • 13. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
    Sui YH, Luo WJ, Xu QY, Hua J.
    World J Gastroenterol; 2016 Feb 28; 22(8):2533-44. PubMed ID: 26937141
    [Abstract] [Full Text] [Related]

  • 14. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
    Zhu W, Feng PP, He K, Li SW, Gong JP.
    Biochem Biophys Res Commun; 2018 Oct 28; 505(2):523-529. PubMed ID: 30269815
    [Abstract] [Full Text] [Related]

  • 15. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
    Lebeaupin C, Vallée D, Rousseau D, Patouraux S, Bonnafous S, Adam G, Luciano F, Luci C, Anty R, Iannelli A, Marchetti S, Kroemer G, Lacas-Gervais S, Tran A, Gual P, Bailly-Maitre B.
    Hepatology; 2018 Aug 28; 68(2):515-532. PubMed ID: 29457838
    [Abstract] [Full Text] [Related]

  • 16. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC.
    J Hepatol; 2017 May 28; 66(5):1037-1046. PubMed ID: 28167322
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin B-mediated Nlrp3 inflammasome activation.
    Wang L, Chen Y, Li X, Zhang Y, Gulbins E, Zhang Y.
    Oncotarget; 2016 Nov 08; 7(45):73229-73241. PubMed ID: 27689324
    [Abstract] [Full Text] [Related]

  • 18. MSC-Derived Small Extracellular Vesicles Alleviate Diabetic Retinopathy by Delivering miR-22-3p to Inhibit NLRP3 Inflammasome Activation.
    Chen Y, Yao G, Tong J, Xie H, Zheng X, Zhang H, Xie Z.
    Stem Cells; 2024 Jan 13; 42(1):64-75. PubMed ID: 37847598
    [Abstract] [Full Text] [Related]

  • 19. RNA adenosine deaminase (ADAR1) alleviates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome.
    Xiang R, Liu Y, Fan L, Jiang B, Wang F.
    Lab Invest; 2022 Oct 13; 102(10):1088-1100. PubMed ID: 35690649
    [Abstract] [Full Text] [Related]

  • 20. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X, Zhang JH, Chen XY, Hu QH, Wang MX, Jin R, Zhang QY, Wang W, Wang R, Kang LL, Li JS, Li M, Pan Y, Huang JJ, Kong LD.
    Antioxid Redox Signal; 2015 Apr 01; 22(10):848-70. PubMed ID: 25602171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.